Nanomedicine: A modern advent for combating COVID-19 Authors Muhammad Ahsan Khan Final Year MBBS Student, Dow University of Health Sciences, Karachi, Pakistan https://orcid.org/0000-0003-0996-7077 Ahya Third Year MBBS Student, Dow University of Health Sciences, Karachi, Pakistan Mishal Shan Siddiqui Final Year MBBS Student, Dow University of Health Sciences, Karachi, Pakistan https://orcid.org/0000-0002-3511-4812 DOI: https://doi.org/10.47391/JPMA.5370 Abstract Madam, Our current understanding of the COVID-19 virus and its vulnerabilities has not been translated into the approval of its standard line of treatment. COVID-19, although primarily a respiratory ailment, may culminate in acute respiratory distress syndrome, hyperinflammatory response, sepsis, and multiorgan failure, which often carry a grave prognosis. Drugs addressing such severities of COVID-19 are often limited by their therapeutic indices, bioavailability, and side effects, necessitating the exploration of new avenues to counter them. The ever-evolving field of nanotechnology presents one such example. Downloads Full Text Article Published 2022-02-12 How to Cite Muhammad Ahsan Khan, Ahya, & Siddiqui, M. S. . (2022). Nanomedicine: A modern advent for combating COVID-19. Journal of the Pakistan Medical Association, 72(6), 1269–1269. https://doi.org/10.47391/JPMA.5370 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 72 No. 6 (2022): June Section Letter to the Editor